Intuitive Surgical Management
Management criteria checks 3/4
Intuitive Surgical's CEO is Dave Rosa, appointed in Jul 2025, has a tenure of less than a year. total yearly compensation is $13.76M, comprised of 5.4% salary and 94.6% bonuses, including company stock and options. directly owns 0.065% of the company’s shares, worth CA$146.27M. The average tenure of the management team and the board of directors is 2.8 years and 6.2 years respectively.
Key information
Dave Rosa
Chief executive officer
US$13.8m
Total compensation
| CEO salary percentage | 5.41% |
| CEO tenure | less than a year |
| CEO ownership | 0.06% |
| Management average tenure | 2.8yrs |
| Board average tenure | 6.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | US$3b |
| Mar 31 2025 | n/a | n/a | US$2b |
| Dec 31 2024 | US$14m | US$745k | US$2b |
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$13m | US$677k | US$2b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$6m | US$626k | US$1b |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$5m | US$607k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$4m | US$590k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$1b |
| Mar 31 2020 | n/a | n/a | US$1b |
| Dec 31 2019 | US$4m | US$574k | US$1b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$1b |
| Dec 31 2018 | US$5m | US$548k | US$1b |
Compensation vs Market: Dave's total compensation ($USD13.76M) is above average for companies of similar size in the Canadian market ($USD7.24M).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Rosa (57 yo)
Mr. David J. Rosa, also known as Dave, served as the Chief Strategy & Growth Officer at Intuitive Surgical, Inc. since January 1, 2022 until May 16, 2023 and had been its President since May 16, 2023 until...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 15.8yrs | US$18.20m | 0.35% CA$ 796.4m | |
| CEO & Director | less than a year | US$13.76m | 0.065% CA$ 146.3m | |
| CFO, Head of Business Technology & Enterprise Technology Leader | 3.8yrs | US$7.03m | 0.0020% CA$ 4.5m | |
| Executive VP and Chief Commercial & Marketing Officer | 2.4yrs | US$6.47m | 0.0022% CA$ 4.9m | |
| Chief Digital Officer | 10.3yrs | US$6.20m | 0.0016% CA$ 3.6m | |
| VP, Principal Accounting Officer & Corporate Controller | 5.8yrs | no data | 0.00013% CA$ 294.1k | |
| Chief Information Officer | less than a year | no data | no data | |
| Chief Legal & Compliance Officer | 3.1yrs | no data | 0.00063% CA$ 1.4m | |
| Executive Vice President of Research | 1.6yrs | no data | no data | |
| Chief Human Resources Officer | 1yr | no data | no data | |
| Chief Medical Officer | 11.7yrs | US$4.48m | 0.00010% CA$ 226.3k | |
| Senior VP & President of Asia Pacific | 10.8yrs | no data | no data |
Experienced Management: ISRG's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 15.8yrs | US$18.20m | 0.35% CA$ 796.4m | |
| CEO & Director | 1.3yrs | US$13.76m | 0.065% CA$ 146.3m | |
| Independent Director | 15.5yrs | US$365.74k | 0.0036% CA$ 8.2m | |
| Independent Director | 5.5yrs | US$354.90k | 0.00087% CA$ 2.0m | |
| Lead Independent Director | 14.5yrs | US$466.66k | 0.0076% CA$ 17.2m | |
| Independent Director | 1.5yrs | US$339.07k | 0.00022% CA$ 497.8k | |
| Independent Director | 8.5yrs | US$361.57k | 0.0018% CA$ 4.0m | |
| Independent Director | 9.8yrs | US$358.24k | 0.00065% CA$ 1.5m | |
| Independent Director | 6.2yrs | US$355.74k | 0.00021% CA$ 475.1k | |
| Independent Director | 4.5yrs | US$355.74k | 0.00065% CA$ 1.5m | |
| Independent Director | 2yrs | US$354.07k | 0.00027% CA$ 610.9k |
Experienced Board: ISRG's board of directors are considered experienced (6.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 06:06 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intuitive Surgical, Inc. is covered by 63 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| null null | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |